Structural effects in vitro of the anti-inflammatory drug diclofenac on human erythrocytes and molecular models of cell membranes

Biophysical Chemistry

Volumn 141, Issue 1, 2009, Pages 34-40

  Suwalsky, Mario ^a   Manrique, Marcela ^a,b   Villena, Fernando ^a   Sotomayor, Carlos P ^c  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

Author keywords

Cell membrane; Diclofenac; Human erythrocytes; Lipid bilayer; Nonsteroidal anti inflammatory drugs

Indexed keywords

ANTIINFLAMMATORY AGENT; DICLOFENAC; DIMYRISTOYLPHOSPHATIDYLCHOLINE;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ERYTHROCYTE FRAGILITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE STRUCTURE; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID BILAYER; MALE; MEMBRANE STRUCTURE; MOLECULAR INTERACTION; MOLECULAR MODEL; MORPHOLOGY; NORMAL HUMAN; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STRUCTURE ACTIVITY RELATION; X RAY DIFFRACTION;

ANTI-INFLAMMATORY AGENTS; CELL MEMBRANE; DICLOFENAC; DIMYRISTOYLPHOSPHATIDYLCHOLINE; ERYTHROCYTES; HUMANS; LIPID BILAYERS; MICROSCOPY, ELECTRON, SCANNING; MODELS, MOLECULAR; PHOSPHATIDYLETHANOLAMINES; SPECTROMETRY, FLUORESCENCE; UNILAMELLAR LIPOSOMES; X-RAY DIFFRACTION;

EID: 60249096530     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2008.12.010     Document Type: Article

References (34)

1. Smalley W.E., Ray W.A., Daughterty J.R., and Griffin M.R. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalization for peptic ulcer disease in elderly persons. Am. J. Epidemiol. 141 (1995) 539-545
2. Tomisato W., Tanaka K., Katsu T., Kakuta H., Sasaki K., Tsutsumi S., Hoshino T., Aburaya M., Li D., Tsuchiya T., Suzuki K., Yokomizo K., and Mizushima T. Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem. Biophys. Res. Commun. 323 (2004) 1032-1039
3. Burke A., Smyth E., and FitzGerald G.A. Analgesic-antipyrectic agents: pharmacotherapy of gout. In: Brunton L.L. (Ed). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. (2006), McGraw-Hill, USA ch. 26
4. Biagini Lopes L., Scarpa M.V., Pereira N.L., Cardoso de Oliveira L., and Gomes Oliveira A. Interaction of sodium diclofenac with freeze-dried soya phosphatidylcholine and unilamellar liposomes. Braz. J. Pharm. Sci. 42 (2006) 497-504
5. Inoue A., Muranaka S., Fujita H., Kanno T., Tamai H., and Utsumi K. Molecular mechanism of diclofenac-induced apoptosis of promyelocytic leukemia: dependency on reactive oxygen species, akt, bid, cytochrome c, and caspase pathway. Free Radic. Biol. Med. 37 (2004) 1290-1299
6. Martindale. In: Reynolds J.E.F. (Ed). The Extra Pharmacopoeia. 30th ed. (1993), The Pharmaceutical Press, London 10-11
7. Lichtenberger L.M. Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem. Pharmacol. 61 (2001) 631-637
8. Giraud M.N., Motta C., Romero J.J., Bommelaer G., and Lichtenberger L.M. Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of non-steroidal anti-inflammatory drugs (NSAIDs). Biochem. Pharmacol. 57 (1999) 247-254
9. Aki H., and Yamamoto M. Biothermodynamic characterization of erythrocyte hemolysis induced by phenotiazine derivatives and anti-inflammatory drugs. Biochem. Pharmacol. 39 (1990) 396-398
10. Masubuchi Y., Nakayama S., and Horie T. Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology 35 (1997) 544-551
11. Chen J.Y., and Huestis W.H. Role of membrane lipid distribution in chlorpromazine-induced shape change of human erythrocytes. Biochim. Biophys. Acta 1323 (1997) 299-309
12. Boon J.M., and Smith B.D. Chemical control of phospholipid distribution across bilayer membranes. Med. Res. Rev. 22 (2000) 251-281
13. Devaux P.F., and Zachowsky A. Maintenance and consequences of membrane phospholipids asymmetry. Chem. Phys. Lipids 73 (1994) 107-120
14. Suwalsky M., Mennickent S., Norris B., Villena F., Cuevas F., and Sotomayor C.P. The antiepileptic drug diphenylhydantoin affects the structure of the human erythrocyte membrane. Z. Naturforsch. 59c (2004) 427-431
15. Suwalsky M., Mennickent S., Norris B., Villena F., and Sotomayor C.P. Effects of the antiepileptic drug carbamazepine on human erythrocytes. Toxicol. In Vitro 20 (2006) 1363-1369
16. Suwalsky M., Villena F., Sotomayor C.P., Bolognin S., and Zatta P. Human cells and cell membrane molecular models are affected in vitro by chlorpromazine. Biophys. Chem. 135 (2008) 7-13
17. Koynova R., and Caffrey M. Phases and phase transitions of the phosphatidylcholines. Biochim. Biophys. Acta 1376 (1998) 91-145
18. Suwalsky M., Rivera C., Villena F., Sotomayor C.P., Jemiola-Rzeminska M., and Strzalka K. Arsenite interactions with phospholipids bilayers as molecular models for the human erythrocyte membrane. Biophys. Chem. 127 (2007) 28-35
19. Parasassi T., and Gratton E. Membrane lipid domains and dynamics as detected by laurdan fluorescence. J. Fluoresc. 5 (1995) 59-69
20. Dodge J.T., Mitchell C., and Hanahan D.J. The preparation and chemical characterization of haemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100 (1963) 119-130
21. J.R. Lakowicz, Principles of Fluorescence Spectroscopy, 2nd ed. Kluwer/Plenum, New York, 1999.
22. Parasassi T., De Stasio G., D'Ubaldo A., and Gratton E. Phase fluctuation in phospholipid membranes revealed by laurdan fluorescence. Biophys. J. 57 (1990) 1179-1186
23. Suwalsky M. Phospholipid bilayers. In: Salamone J.C. (Ed). Polymeric Materials Encyclopedia vol. 7 (1996), CRC, Boca Raton, FL 5073-5078
24. Uyemura S.A., Santos A.C., Mingatto F.E., Jordani M.C., and Curti C. Diclofenac sodium and mefenamic acid: potent inducers of the membrane permeability transition in renal cortex mitochondria. Arch. Biochem. Biophys. 342 (1997) 231-235
25. Mingatto F.E., Santos A.C., Uyemura S.A., Jordani M.C., and Curti C. In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis. Arch. Biochem. Biophys. 334 (1996) 303-308
26. Ferreira H., Lúcio M., Lima J.L.F.C., Cordeiro-da-Silva A., Tavares J., and Reis S. Effect of anti-inflammatory drugs on splenocyte membrane fluidity. Anal. Biochem. 339 (2005) 144-149
27. Siu W.P., Pun P.B.L., Latchoumycandane C., and Boelsterli U.A. Bax-mediated mitochondrial outer membrane permeabilization (MOMP), distinct from the mitochondrial permeability transition, is a key mechanism in diclofenac-induced hepatocyte injury: multiple protective roles of cyclosporine A. Toxicol. Appl. Pharmacol. 227 (2008) 451-461
28. + current in rat granule cells. Neuropharmacol. 48 (2005) 918-926
29. Orhan H., and Sahin G. In vitro effects of NSAIDS and paracetamol on oxidative stress-related parameters of human erythrocytes. Exp. Toxicol. Pathol. 53 (2001) 133-140
30. Souza S.M.B., Oliveira Jr. O.N., Scarpa M.V., and Oliveira A.G. Study of the diclofenac/phospholipid interactions with liposomes and monolayers. Colloids Surf. B 36 (2004) 13-17
31. Lopes L.B., Scarpa M.V., Silva G.V.J., Rodrigues D.C., Santillini C.V., and Oliveira A.G. Studies on the encapsulation of diclofenac in small unilamellar liposomes of soya phosphatidylcholine. Colloids Surf. B 39 (2004) 151-158
32. Schrier S.L., Zachowski A., and Devaux P.F. Mechanisms of amphipath-induced stomatocytosis in human erythrocytes. Blood 79 (1992) 782-786
33. Svetina S., Kuzman D., Waugh R.E., Zibert P., and Zeks B. The cooperative role of membrane skeleton and bilayer in the mechanical behaviour of red blood cells. Bioelectrochem. 62 (2004) 107-113
34. Winski S.L., and Carter D.E. Arsenate toxicity in human erythrocytes: characterization of morphological changes and determination of the mechanism of damage. J. Toxicol. Env. Health, Part A 53 (1998) 345-355